Transurethral evaporation treats benign prostatic hyperplasia (BPH):
This article was originally published in Clinica
Executive Summary
Transurethral evaporation of the prostate can cut irratative voiding complications to 22.6% say researchers from the University of Florida in Gainesville and the University of New Mexico in Albuquerque. The researchers used the technique to treat effectively benign prostatic hyperplasia (BPH) in a 168-patient study at two US sites. They found complications associated with the treatment were minimal after 12-month follow up. Patients also demonstrated a significant improvement in mean peak flow rate from 8.2 to 18.2 cm3 per second reports the Journal of Urology (Vol 157, p 1309-1312).
You may also be interested in...
Corindus Envisions Network Of CorPath Robots For Remote Neurovascular And Coronary Interventions
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Hikma And Civica Ship Eight Essential Injectables
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: